Expression of resolvin D1 biosynthetic pathways in salivary epithelium

Journal of Dental Research

Volumn 93, Issue 3, 2014, Pages 300-305

  Leigh, N J ^a   Nelson, J W ^a   Mellas, R E ^a   Aguirre, A ^a   Baker, O J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

cell biology; epithelia; inflammation; lipids; resolvins; Sj gren's syndrome

Indexed keywords

12 15 LIPOXYGENASE; 12-15-LIPOXYGENASE; ALOX15 PROTEIN, HUMAN; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2; DOCOSAHEXAENOIC ACID; LIPID; RESOLVIN D1;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL MEMBRANE; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; CYTOSOL; ENZYMOLOGY; EPITHELIA; EPITHELIUM; FEMALE; HUMAN; INBRED MOUSE STRAIN; INFLAMMATION; METABOLISM; MINOR SALIVA GLAND; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; RESOLVINS; SJOEGREN SYNDROME; SJÖGREN'S SYNDROME; SUBMANDIBULAR GLAND;

CELL BIOLOGY; EPITHELIA; INFLAMMATION; LIPIDS; RESOLVINS; SJÖGREN'S SYNDROME;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONATE 5-LIPOXYGENASE; CELL CULTURE TECHNIQUES; CELL MEMBRANE; CELLS, CULTURED; CYTOSOL; DOCOSAHEXAENOIC ACIDS; EPITHELIUM; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, INBRED STRAINS; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; PHOSPHOLIPASES A2, CYTOSOLIC; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND;

EID: 84894443560     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034513519108     Document Type: Article

References (28)

1. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007 ; 28: 176-183
2. Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu M, Sibilia J, et al. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006 ; 54: 2243-2249
3. Burke JE, Dennis EA. Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res. 2009 ; 50: S237 - S242
4. Delaleu N, Jonsson R, Koller MM. Sjögren's syndrome. Eur J Oral Sci. 2005 ; 113: 101-113
5. Fox PC, Speight PM. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome. Crit Rev Oral Biol Med. 1996 ; 7: 144-158
6. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol. 1994 ; 152: 5532-5539
7. Fredman G, Serhan CN. Specialized pro-resolving mediators: wiring the circuitry of effector immune and tissue homeostasis. Endodontic Topics. 2011 ; 24: 39-58
8. Hassan IR, Gronert K. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J Immunol. 2009 ; 182: 3223-3232
9. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem. 2003 ; 278: 14677-14687
10. Hong S, Tjonahen E, Morgan EL, Lu Y, Serhan CN, Rowley AF. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins - mediator lipidomic analysis. Prostaglandins Other Lipid Mediat. 2005 ; 78: 107-116
11. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren's syndrome. Oral Dis. 2002 ; 8: 130-140
12. Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D, et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol. 2008 ; 181: 8677-8687
13. Kelavkar UP, Glasgow W, Olson SJ, Foster BA, Shappell SB. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Neoplasia. 2004 ; 6: 821-830
14. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA. 2010 ; 107: 1660-1665
15. Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem. 1997 ; 272: 16709-16712
16. Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE. Resolvin e1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther. 2010 ; 26: 431-439
17. McCall AD, Nelson JW, Leigh NJ, Duffey ME, Lei P, Andreadis ST, et al. Growth factors polymerized within fibrin hydrogel promote amylase production in parotid cells. Tissue Eng Part A. 2013 ; 19: 2215-2225.
18. Nelson J, Leigh N, Mellas R, McCall A, Aguirre A, Baker OJ. The ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. Am J Physiol Cell Physiol. 2014 ; 306: C178 - C185
19. Odusanwo O, Chinthamani S, McCall A, Duffey ME, Baker OJ. Resolvin D1 prevents TNF-alpha-mediated disruption of salivary epithelial formation. Am J Physiol Cell Physiol. 2012 ; 302: C1331 - C1345
20. Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008 ; 153: S200-215
21. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al. Resolvins - a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002 ; 196: 1025-1037
22. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008 ; 8: 349-361
23. Shikano M, Masuzawa Y, Yazawa K. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1. J Immunol. 1993 ; 150 (8 Pt 1). 3525-3533
24. Shikano M, Masuzawa Y, Yazawa K, Takayama K, Kudo I, Inoue K. Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine. Biochim Biophys Acta. 1994 ; 1212: 211-216
25. Strokin M, Sergeeva M, Reiser G. Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol. 2003 ; 139: 1014-1022
26. Sun GY, Xu J, Jensen MD, Simonyi A. Phospholipase A2 in the central nervous system implications for neurodegenerative diseases. J Lipid Res. 2004 ; 45: 205-213
27. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, et al. Resolvin D1 and its aspirin-triggered 17R epimer stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem. 2007 ; 282: 9323-9334
28. Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol. 2010 ; 6: 529-537